Department of Pediatrics ~ New Therapies for Children with Relapsed AML

EVENT DETAILS AND REGISTRATION

Date:November 11, 2016

Time: 12:00 PM - 01:00 PM (PT)

Location:Needleman I

Event Is:

  • Discuss current clinical trials for patients with relapsed Acute Myeloid Leukemia (AML)
  • Distinguish trials that are limited to specific subgroups of patients from those that are open to all patients with relapsed AML
  • Examine the potential advantages of enrolling patients on clinical trials compared to treating these patients with non-protocol therapy

Presenters:Jeffrey Rubnitz, MD, PhD

ADDITIONAL DETAILS:

Objectives:

  • Discuss current clinical trials for patients with relapsed Acute Myeloid Leukemia (AML)
  • Distinguish trials that are limited to specific subgroups of patients from those that are open to all patients with relapsed AML
  • Examine the potential advantages of enrolling patients on clinical trials compared to treating these patients with non-protocol therapy

Who should attend:

Pediatric Hematology/Oncology Physicians, Advance Practice Practitioners, staff and research team

CME credits:1.0 AMA/PRA Category 1 Credit™ The City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. City of Hope designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.TM

R.S.V.P.: Please Contact Jennifer James at Ext. 88442

Contact:

Jennifer James